Box Inc: Form 10-Q for the period ended Oct 31, 2023
Filed with the SEC on Dec 6, 2023 and accepted by EDGAR at Dec 6, 2023, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-08-01 to 2023-10-31 | $261.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-02-01 to 2023-10-31 | $774.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-08-01 to 2023-10-31 | $69.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-02-01 to 2023-10-31 | $197.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-08-01 to 2023-10-31 | $192.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-02-01 to 2023-10-31 | $577.0m | us-gaap:GrossProfit |
| Research and development | 3 months2023-08-01 to 2023-10-31 | $61.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-02-01 to 2023-10-31 | $186.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-08-01 to 2023-10-31 | $11.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-02-01 to 2023-10-31 | $29.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-08-01 to 2023-10-31 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-02-01 to 2023-10-31 | $7.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-08-01 to 2023-10-31 | $10.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-02-01 to 2023-10-31 | $29.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-08-01 to 2023-10-31 | $0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-02-01 to 2023-10-31 | $0.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-08-01 to 2023-10-31 | $0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-02-01 to 2023-10-31 | $0.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-08-01 to 2023-10-31 | 147,625,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-02-01 to 2023-10-31 | 149,351,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-02-01 to 2023-10-31 | $229.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 9 months2023-02-01 to 2023-10-31 | $155.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-10-31 | $377.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-10-31 | $684.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-10-31 | $1.03bn | us-gaap:Assets |
| Current liabilities | At period end2023-10-31 | $570.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-10-31 | $1.08bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-10-31 | $370.3m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2023-10-31 | −$540.4m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-10-31 | 143,591,373 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-068562. Last ingested by Listed: Oct 27, 2026, 19:40 ET. Listed shows no prices and gives no investment advice.